Acutus Medical Inc
NASDAQ:AFIB
Income Statement
Earnings Waterfall
Acutus Medical Inc
Revenue
|
19.7m
USD
|
Cost of Revenue
|
-31.8m
USD
|
Gross Profit
|
-12.1m
USD
|
Operating Expenses
|
-59.7m
USD
|
Operating Income
|
-71.9m
USD
|
Other Expenses
|
39.1m
USD
|
Net Income
|
-32.8m
USD
|
Income Statement
Acutus Medical Inc
Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
6
N/A
|
8
+44%
|
10
+24%
|
14
+34%
|
15
+10%
|
17
+12%
|
17
+1%
|
17
-4%
|
16
-6%
|
16
+4%
|
17
+3%
|
18
+7%
|
20
+9%
|
|
Gross Profit | ||||||||||||||
Cost of Revenue |
(11)
|
(16)
|
(20)
|
(24)
|
(28)
|
(33)
|
(33)
|
(35)
|
(34)
|
(32)
|
(32)
|
(30)
|
(32)
|
|
Gross Profit |
(5)
N/A
|
(7)
-45%
|
(9)
-24%
|
(10)
-14%
|
(12)
-19%
|
(16)
-26%
|
(16)
+1%
|
(18)
-18%
|
(18)
+3%
|
(16)
+12%
|
(15)
+4%
|
(12)
+19%
|
(12)
0%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(58)
|
(84)
|
(92)
|
(99)
|
(98)
|
(96)
|
(94)
|
(93)
|
(86)
|
(77)
|
(70)
|
(63)
|
(60)
|
|
Selling, General & Administrative |
(35)
|
(50)
|
(56)
|
(63)
|
(63)
|
(64)
|
(62)
|
(60)
|
(54)
|
(48)
|
(43)
|
(38)
|
(36)
|
|
Research & Development |
(24)
|
(33)
|
(35)
|
(36)
|
(37)
|
(37)
|
(35)
|
(34)
|
(31)
|
(28)
|
(26)
|
(25)
|
(24)
|
|
Other Operating Expenses |
1
|
(0)
|
(1)
|
(0)
|
2
|
4
|
3
|
1
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
Operating Income |
(63)
N/A
|
(91)
-44%
|
(102)
-11%
|
(109)
-8%
|
(110)
-1%
|
(112)
-2%
|
(110)
+2%
|
(111)
-1%
|
(103)
+7%
|
(92)
+11%
|
(85)
+8%
|
(75)
+12%
|
(72)
+5%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
23
|
21
|
57
|
71
|
37
|
41
|
|
Total Other Income |
(6)
|
(6)
|
(6)
|
(4)
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
|
Pre-Tax Income |
(73)
N/A
|
(102)
-40%
|
(113)
-11%
|
(119)
-5%
|
(116)
+2%
|
(118)
-2%
|
(129)
-9%
|
(94)
+27%
|
(86)
+9%
|
(40)
+54%
|
(16)
+60%
|
(40)
-152%
|
(33)
+18%
|
|
Net Income | ||||||||||||||
Tax Provision |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(73)
|
(102)
|
(113)
|
(119)
|
(116)
|
(118)
|
(129)
|
(94)
|
(86)
|
(40)
|
(16)
|
(40)
|
(33)
|
|
Net Income (Common) |
(73)
N/A
|
(102)
-41%
|
(113)
-11%
|
(119)
-5%
|
(116)
+2%
|
(118)
-2%
|
(129)
-9%
|
(94)
+27%
|
(86)
+9%
|
(40)
+54%
|
(16)
+60%
|
(40)
-151%
|
(33)
+18%
|
|
EPS (Diluted) |
-4.51
N/A
|
-8.94
-98%
|
-4.03
+55%
|
-4.21
-4%
|
-3.8
+10%
|
-4.11
-8%
|
-4.57
-11%
|
-3.31
+28%
|
-3.03
+8%
|
-1.4
+54%
|
-0.56
+60%
|
-1.39
-148%
|
-1.12
+19%
|